Skip to main content

Advertisement

SpringerLink
Log in

Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Looney WJ, Narita M, Muhlemann K (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312–323

    Article  CAS  PubMed  Google Scholar 

  2. Fihman V, Le Monnier A, Corvec S et al (2012) Stenotrophomonas maltophilia—the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect 64:391–398

    Article  PubMed  Google Scholar 

  3. Bao H, Qiao Y, Liu D et al (2020) The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience. Infection 48:205–212

    Article  CAS  PubMed  Google Scholar 

  4. Bassetti M, Echols R, Matsunaga Y et al (2021) Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis 21:226–240

    Article  CAS  PubMed  Google Scholar 

  5. Wunderink RG, Matsunaga Y, Ariyasu M et al (2021) Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 21:213–225

    Article  CAS  PubMed  Google Scholar 

  6. Gajdacs M, Urban E (2019) Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Health Serv Res Manag Epidemiol 6:1–9

    Google Scholar 

  7. Biagi M, Vialichka A, Jurkovic M et al (2020) Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia. Antimicrob Agents Chemother 64:e00559-e620

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine and Surgery, Infectious Diseases Unit, University of Naples Federico II, Naples, Italy

    Emanuela Zappulo, Biagio Pinchera, Antonio Riccardo Buonomo & Ivan Gentile

  2. Department of Clinical Medicine and Surgery, Hematology Unit, University of Naples Federico II, Naples, Italy

    Francesco Grimaldi, Marco Picardi & Fabrizio Pane

  3. Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy

    Rossella Paolillo & Maria Rosaria Catania

Authors
  1. Emanuela Zappulo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Grimaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rossella Paolillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Biagio Pinchera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Riccardo Buonomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marco Picardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maria Rosaria Catania
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fabrizio Pane
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ivan Gentile
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

FG, MP, FP, and EZ were involved in the patient’s care; RP and MRC performed and supervised the microbiological analysis; E.Z. wrote the manuscript; FG, IG, BP, ARB, and RV edited the manuscript.

Corresponding author

Correspondence to Francesco Grimaldi.

Ethics declarations

Competing interests

All the authors declare they have no conflict of interest in connection with the submitted article. IG acted as a consultant for MSD, Abbvie, Gilead, Pfizer, GSK, Nordic, Angelini, Abbott, and received department grants from Gilead. All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. An informed consent was obtained for all procedures in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zappulo, E., Grimaldi, F., Paolillo, R. et al. Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy. Ann Hematol 101, 2805–2806 (2022). https://doi.org/10.1007/s00277-022-05006-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-05006-3

Search

Navigation